Analytical Strategies for the Determination of Norepinephrine Reuptake Inhibitors in Pharmaceutical Formulations and Biological Fluids

References

• Abbas, S. S.; Elghobashy, M. R.; Shokry, R. F.; Bebawy, L. I. Stability Indicating HPLC and Spectrophotometric Methods for the Determination of Bupropion Hydrochloride in the Presence of Its Alkaline Degradates and Related Impurity. Bull. Faculty Pharm. Cairo Univ. 2012, 50, 49–59.
   Google Scholar
• Abdulaziz, M. A. S.; Basavaiah, K.; Vinay, K. B. Titrimetric and Spectrophotometric Assay of Bupropion Hydrochloride in Pharmaceuticals Using Mercury (II) Nitrate. Eclét. Quím. 2010, 35, 9–16.
   Google Scholar
• Abdulrahman, S. A. M.; Basavaiah, K. Application of Ion-Assocıation Titration for the Assay of Bupropion Hydrochloride in Pharmaceuticals. Chem. Ind. Chem. Eng. Q. 2011, 17, 299–306.
   Web of Science ®Google Scholar
• Akamatsu, S.; Mitsuhashi, T. Simultaneous Determination of Pharmaceutical Components in Dietary Supplements for Weight Loss by Capillary Electrophoresis Tandem Mass Spectrometry. Drug Test. Anal. 2014, 6, 426–433.
   PubMed Web of Science ®Google Scholar
• Al Azzam, K. M.; Saad, B.; Aboul-Enein, H. Y. Determination of the Binding Constants of Modafinil Enantiomers with Sulfated β-Cyclodextrin Chiral Selector by Capillary Electrophoresis Using Three Different Linear Plotting Models. Electrophoresis 2010, 31, 2957–2963.
   PubMed Web of Science ®Google Scholar
• Al-Khamis, K. I. Rapid Determination of Bupropion in Human Plasma by High-Performance Liquid Chromatography. J. Liq. Chromatogr. 1989, 12, 645–655.
   Web of Science ®Google Scholar
• Almeida, A. E.; Ribeiro, M. L. High-Performance Liquıd Chromatographic Determınation of Amfepramone Hydrochloride, Mazindol, and Diazepam in Tablets. J. Liq. Chromatogr. Relat. Technol. 1999, 22, 1759–1769.
   Web of Science ®Google Scholar
• Altunöz-Erdoğan, D.; Erk, N.; Kılıç, E. Voltammetric Methods of Reboxetine Analysis and the Mechanism of Its Electrode Reactions. Cent. Eur. J. Chem. 2013, 11, 706–716.
   Google Scholar
• Appel, D. I.; Brinda, B.; Markowitz, J. S.; Newcorn, J. H.; Zhua, H.-J. A Liquid Chromatography/Tandem Mass Spectrometry Assay for the Analysis of Atomoxetine in Human Plasma and in Vitro Cellular Samples. Biomed. Chromatogr. 2012, 26, 1364–1370.
   PubMed Web of Science ®Google Scholar
• Asensi-Bernardi, L.; Escuder-Gilabert, L.; Martín-Biosca, Y.; Sagrado, S.; Medina-Hernández, M. J. Characterizing the Interaction between Enantiomers of Eight Psychoactive Drugs and Highly Sulfated-β-Cyclodextrin by Counter-Current Capillary Electrophoresis. Biomed. Chromatogr. 2014, 28, 120–126.
   PubMed Web of Science ®Google Scholar
• Basavaiah, K.; Abdulrahman, S. A. M. Use of Charge Transfer Complexation Reaction for the Spectrophotometric Determination of Bupropion in Pharmaceuticals and Spiked Human Urine. Thai J. Pharm. Sci. 2010, 34, 134–145.
   Google Scholar
• Bhattacharyya, S. P.; Bhattacharyya, S. S. Chromatographic Method for the Analysis of Bupropion Hydrochloride in Pharmaceutical Dosage Form. Int. J. Pharm. Technol. 2010, 2, 224–232.
   PubMedGoogle Scholar
• Borges, V.; Yang, E.; Dunn, J.; Henion, J. High-Throughput Liquid Chromatography–Tandem Mass Spectrometry Determination of Bupropion and Its Metabolites in Human, Mouse and Rat Plasma Using Amonolithic Column. J. Chromatogr. B 2004, 804, 277–287.
   PubMed Web of Science ®Google Scholar
• Bourland, J. A.; Collins, A. A.; Chester, S. A.; Ramachandran, S.; Backer, R. C. Determination of Tapentadol (Nucynta®) and N-Desmethyltapentadol in Authentic Urine Specimens by Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry. J. Anal. Toxicol. 2010, 34, 450–457.
   PubMed Web of Science ®Google Scholar
• Cakrt, M.; Buzinkaiová, T.; Polonský, J.; Korínková, V. Spectrofluorimetric and Isotachophoretic Determination of Maprotiline in Human Blood Serum. Electrophoresis 2000, 21, 2834–2838.
   PubMed Web of Science ®Google Scholar
• Castro-Puyana, M.; Lammers, I.; Buijs, J.; Gooijer, C.; Ariese, F. Sensitized Phosphorescence as Detection Method for the Enantioseparation of Bupropion by Capillary Electrophoresis. Electrophoresis 2010, 31, 3928–3936.
   PubMed Web of Science ®Google Scholar
• Chankvetadze, B. Enantioseparations by Using Capillary Electrophoretic Techniques. The Story of 20 and a Few More Years. J. Chromatogr. A 2007, 1168, 45–70.
   PubMed Web of Science ®Google Scholar
• Chen, J.; Li, Z. Determination of Bupropion Hydrochloride in Tablet by HPLC. West China J. Pharm. Sci. 2009, 5, 036.
   Google Scholar
• Chen, Z.; Weber, S. G. Determination of Binding Constants by Affinity Capillary Electrophoresis, Electrospray Ionization Mass Spectrometry and Phase-Distribution Methods. TrAC Trends Anal. Chem. 2008, 27, 738–748.
   PubMed Web of Science ®Google Scholar
• Chhabra, G.; Jain, C.; Banerjee, S. K. Development and Validation of RP-HPLC Method for the Determination of Atomoxetine Hydrochloride in Pharmaceutical Dosage Forms. Int. J. Drug Dev. Res. 2011, 3, 275–279.
   Google Scholar
• Choi, C.-I.; Bae, J.-W.; Lee, H.-I.; Jang, C.-G.; Sohn, U. D.; Lee, S.-Y. Determination of Atomoxetine Metabolites in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study. J. Chromatogr. B 2012, 885–886, 103–108.
   PubMed Web of Science ®Google Scholar
• Choong, E.; Rudaz, S.; Kottelat, A.; Guillarme, D.; Veuthey, J. L.; Eap, C. B. Therapeutic Drug Monitoring of Seven Psychotropic Drugs and Four Metabolites in Human Plasma by HPLC-MS. J. Pharm. Biomed. Anal. 2009, 50, 1000–1008.
   PubMed Web of Science ®Google Scholar
• Choong, E.; Rudaz, S.; Kottelat, A.; Haldemann, S.; Guillarme, D.; Veuthey, J. L.; Eap, C. B. Quantification of 4 Antidepressants and a Metabolite by LC–MS for Therapeutic Drug Monitoring. J. Chromatogr. B 2011, 879, 1544–1550.
   PubMed Web of Science ®Google Scholar
• Coles, R.; Kharasch, E. D. Stereoselective Analysis of Bupropion and Hydroxybupropion in Human Plasma and Urine by LC/MS/MS. J. Chromatogr. B 2007, 857, 67–75.
   PubMed Web of Science ®Google Scholar
• Cooper, T. B.; Suckow, R. F.; Glassman, A. Determination of Bupropion and Its Major Basic Metabolites in Plasma by Liquid Chromatography with Dual-Wavelength Ultraviolet Detection. J. Pharm. Sci. 1984, 73, 1104–1111.
   PubMed Web of Science ®Google Scholar
• Coulter, C.; Taruc, M.; Tuyay, J.; Moore, C. Determination of Tapentadol and Its Metabolite N-Desmethyltapentadol in Urine and Oral Fluid Using Liquid Chromatography with Tandem Mass Spectral Detection. J. Anal. Toxicol. 2010, 34, 458–463.
   PubMed Web of Science ®Google Scholar
• de Oliveira, M. H.; Carlos, G.; Bergold, A. M.; Pechansky, F.; Limberger, R. P.; Fröehlich, P. E. Determination of Mazindol in Human Oral Fluid by High Performance Liquid Chromatography–Electrospray Ionization Mass Spectrometry. Biomed. Chromatogr. 2014, 28(8), 1064–1069. DOI:10.1002/bmc.3120
   PubMed Web of Science ®Google Scholar
• Delazzeri, L.; Borba, S. B.; Bergold, A. M. Development and Validation of a Chromatographic Method for the Determination of Bupropion Hydrochloride. Rev. Cienc. Farm. Basica Apl. 2005, 26, 211–217.
   Google Scholar
• Denooz, R.; Mercerolle, M.; Lachâtre, G.; Charlier, C. Ultra-performance Liquid Chromatography–Tandem Mass Spectrometry Method for the Determination of Bupropion and Its Major Metabolites in Human Whole Blood. J. Anal. Toxicol. 2010, 34, 280–286.
   PubMed Web of Science ®Google Scholar
• Erk, N. Extractive Spectrophotometric Methods for the Novel Antidepressant Drug in Bulk and Pharmaceutical Dosage Forms by Using Bromthymol Blue and Bromcresol. Green Anal. Lett. 2003, 36, 1183–1196.
   Web of Science ®Google Scholar
• Ersoy, L.; Alpertunga, B. Spectrophotometric Determination of Maprotiline Hydrochloride. Analyst 1988, 113, 1745–1746.
   PubMed Web of Science ®Google Scholar
• Fazio, A.; Crisafulli, P.; Primerano, G.; D’Agostino, A. A.; Oteri, G.; Pisani, F. A Sensitive Gas Chromatographic Assay for the Determination of Serum Viloxazine Concentration Using a Nitrogen-Phosphorus-Selective Detector. Ther. Drug Monit. 1984, 6, 484–488.
   PubMed Web of Science ®Google Scholar
• Fejős, I.; He, Y.; Völgyi, G.; Kazsoki, A.; Sun, J.; Chen, W.; Sohajda, T.; Szente, L.; Jiang, X.; Béni, S. Tapentadol Enantiomers: Synthesis, Physico-Chemical Characterization and Cyclodextrin Interactions. J. Pharm. Biomed. Anal. 2014, 88, 594–601.
   PubMed Web of Science ®Google Scholar
• Ficarra, R.; Calabro M. L.; Tommasini, S.; Melardi, S.; Cutroneo, P.; Ficarra, P. Direct Separation of the Enantiomers of Reboxetine by Liquid Chromatography on Different Cellulose- and Amylose-Based Chiral Stationary Phases. Chromatographia 2001, 53, 261–265.
   Web of Science ®Google Scholar
• Frahnert, C.; Rao, M. L.; Grasmader, K. Analysis of Eighteen Antidepressants, Four Atypical Antipsychotics and Active Metabolites in Serum by Liquid Chromatography: A Simple Tool for Therapeutic Drug Monitoring. J. Chromatogr. B 2003, 794, 35–47.
   PubMed Web of Science ®Google Scholar
• Frigerio, E.; Benecchi, A.; Brianceschi, G.; Pellizzoni, C.; Poggesi, I.; Benedetti, M. S.; Dostert, P. Pharmacokinetics of Reboxetine Enantiomers in the Dog. Chirality 1997, 9, 303–306.
   PubMed Web of Science ®Google Scholar
• Frigerio, E.; Pianezzola, E.; Strolin, B. M. Sensitive Procedure for the Determination of Reboxetine Enantiomers in Human Plasma by Reversed-Phase High-Performance Liquid Chromatography with Fluorimetric Detection after Chiral Derivatization with (+)-1-(9-Fluorenyl)ethyl chloroformate. J. Chromatogr. A 1994, 660, 351–358.
   PubMed Web of Science ®Google Scholar
• Garrido, E. M. P. J.; Garrido, J. M. P. J.; Esteves, M.; Santos-Silva, A.; Marques, M. P. M.; Borges, F. Voltammetric and DFT Studies on Viloxazine: Analytical Application to Pharmaceuticals and Biological Fluids. Electroanalysis 2012, 13, 1454–1462.
   Google Scholar
• Gasior, M.; Bergman, J.; Kallman, M. J.; Paronis, C. A. Evaluation of the Reinforcing Effects of Monoamine Reuptake Inhibitors under a Concurrent Schedule of Food and i.v. Drug Delivery in Rhesus Monkeys. Neuropsychopharmacology 2005, 30, 758–764.
   PubMed Web of Science ®Google Scholar
• Gavin, P. F.; Olsen, B. A. A Quality by Design Approach to Impurity Method Development for Atomoxetine Hydrochloride (LY139603). J. Pharm. Biomed. Anal. 2008, 46, 431–441.
   PubMed Web of Science ®Google Scholar
• Gifford, L. A.; Witts D. J. Sensıtıve Method for the Determınatıon of Tandamıne Hydrochlorıde in Plasma Usıng a Specıfıc Nıtrogen Detector. Br. J. Clin. Pharmacol. 1976, 3, 337–339.
   PubMed Web of Science ®Google Scholar
• Gillilan, R.; Mason, W. D. High-Pressure Liquid Chromatographic Determination of Viloxazine in Human Plasma and Urine. J. Pharm. Sci. 1981, 70(2), 220–221.
   PubMed Web of Science ®Google Scholar
• Giorgim, M.; Meizler, A.; Mills, P. C. Quantification of Tapentadol in Canine Plasma by HPLC with Spectrofluorimetric Detection: Development and Validation of a New Methodology. J. Pharm. Biomed. Anal. 2012, 67, 148–153.
   PubMed Web of Science ®Google Scholar
• Goud, E. S. K.; Reddy, V. K. RP-HPLC Determınatıon of Related Substances of Tapentadol in Bulk and Pharmaceutıcal Dosage Form. Int. J. Pharm. Biol. Sci. 2012, 2, 01–09.
   Google Scholar
• Groppi, A.; Papa, P. One-Step Extraction Procedure for Gas Chromatographic Determination of Viloxazine as Its Acetyl Derivative in Human Plasma. J. Chromatogr. 1985, 337, 142–145.
   PubMed Web of Science ®Google Scholar
• Guo, W.; Li, W.; Guo, G.; Zhang, J.; Zhou, B., Zhai, Y.; Wang, C. Determination of ATX in Human Plasma by a High Performance Liquid Chromatographic Method with Ultraviolet Detection Using Liquid–Liquid Extraction. J. Chromatogr. B 2007, 854, 128–134.
   PubMed Web of Science ®Google Scholar
• Gutteck, U.; Rentsch, K. M. Therapeutic Drug Monitoring of 13 Antidepressant and Five Neuroleptic Drugs in Serum with Liquid Chromatography-Electrospray Ionization Mass Spectrometry. Clin. Chem. Lab. Med. 2003, 41, 1571–1579.
   PubMed Web of Science ®Google Scholar
• Härtter, S.; Weigmann, H.; Hiemke, C. Automated Determination of Reboxetine by High-Performance Liquid Chromatography with Column-Switching and Ultraviolet Detection. J. Chromatogr. B 2000, 740, 135–140.
   PubMed Web of Science ®Google Scholar
• Hu, L.; Wang, Z.; Xu, R.; Ma, J.; Wang, X.; Zhang, X. Determination of Bupropion and Its Main Metabolite in Rat Plasma by LC-MS and Its Application to Pharmacokinetics. Pharmazie 2011, 66, 924–928.
   PubMed Web of Science ®Google Scholar
• Iche, P. P. Stress Degradation Studies of Bupropion hcl and Development of a Validated UV Spectrophotometric Method in Bulk and Pharmaceutical Dosage Form. Int. J. Pharm. Pharm. Sci. Res. 2013, 3, 103–107.
   Google Scholar
• Ishaq, B. M.; Ahad, H. A.; Muneer, S.; Praveena, B. Colorimetric Assay of Atomoxetine Hydrochloride by Simple Aurum Coupling Reaction in Bulk and Tablet Dosage Form. Int. J. Res. Phar. Life Sci. 2013, 1, 77–80.
   Google Scholar
• Ishida, J.; Horike, N.; Yamaguchi, M. Determination of Maprotiline in Plasma by High-Performance Liquid Chromatography with Chemiluminescence Detection. J. Chromatogr. B 1995, 669, 390–396.
   PubMed Web of Science ®Google Scholar
• Jagadeesh, B. V. V. S.; Raju, S. S.; Rao, V. J.; Rao, S. J. V. L. N. Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms. Asian J. Chem. 2009, 21, 829–833.
   Google Scholar
• Jain, D.; Basniwal, P. K. Determination of Tapentadol Hydrochloride in Tablets by Three New Validated Spectrophotometric Methods. Pak. J. Anal. Environ. Chem. 2013a, 14, 38–43.
   Google Scholar
• Jain, D.; Basniwal, P. K. ICH Guideline Practice: Application of Validated RP-HPLC-DAD Method for Determination of Tapentadol Hydrochloride in Dosage Form. J. Anal. Sci. Technol. 2013b, 4, article 9.
   Google Scholar
• Jennison, T. A.; Brown, P.; Crossett, J.; Urry, F. M. A High Performance Liquid Chromatographic Method for Quantitating Bupropion in Human Plasma or Serum. J. Anal. Toxicol. 1995, 19, 69–72.
   PubMed Web of Science ®Google Scholar
• Jindal, S. P.; Lutz, T.; Vestergaard, P. GLC-Mass Spectrometric Determination of Maprotiline and Its Major Metabolite Using Stable Isotope-Labeled Analog as Internal Standard. J. Pharm. Sci. 1980, 69, 684–687.
   PubMed Web of Science ®Google Scholar
• Kaddoumi, A.; Mori, M.; Nanashima, K.; Kono, M.; Nakashima, K. High Performance Liquid Chromatographic Determination of Mazindol in Human Plasma. Analyst 2001, 126, 1963–1968.
   PubMed Web of Science ®Google Scholar
• Kamat, S. S.; Choudhari, V. B.; Vele, V. T.; Prabhune, S. S. RP-LC Determination of Atomoxetine HCl from Its Pharmaceutical Dosage Form. Chromatographia 2008, 67, 143–146.
   Web of Science ®Google Scholar
• Kathirvel, S.; Madhu, B. K. A Validated Method for the Determination of Tapentadol Hydrochloride in Bulk and Its Pharmaceutical Formulation by Densitometric Analysis. Indian Drugs 2012, 49, 51–55.
   Google Scholar
• Keating, J. Measurement of Plasma Serotonin by High-Performance Liquid Chromatography with Electrochemical Detection as an Index of the in Vivo Activity of Fluvoxamine. J. Chromatogr. B 1993, 615, 237–242.
   Web of Science ®Google Scholar
• Khalil, N. Y. A Highly Sensitive HPLC Method with Automated On-Line Sample Pre-treatment and Fluorescence Detection for Determination of Reboxetine in Human Plasma. Talanta 2010, 80, 1251–1256.
   PubMed Web of Science ®Google Scholar
• Kim, S. S.; Lee, H. W.; Lee, K. T. Validated Method for Determination of Mazindol in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry. J. Chromatogr. B 2009, 877, 1011–1016.
   PubMed Web of Science ®Google Scholar
• Kirchherr, H.; Kuhn-Velten, W. N. Quantitative Determination of Forty-Eight Antidepressants and Antipsychotics in Human Serum by HPLC Tandem Mass Spectrometry: A Multi-Level, Single-Sample Approach. J. Chromatogr. B 2006, 843, 100–113.
   PubMed Web of Science ®Google Scholar
• Liu, Y-Y.; Sun, L.; Di, X.; Sun, Y-Q. Determination of Bupropion Hydrochloride in Human Plasma by HPLC. J. Shenyang Pharm. Univ. 2007, 5.
   Google Scholar
• Loboz, K. K.; Gross, A. S.; Ray, J.; McLachlan, A. J. HPLC Assay for Bupropion and Its Major Metabolites in Human Plasma. J. Chromatogr. B 2005, 823, 115–121.
   PubMed Web of Science ®Google Scholar
• Marchei, E.; Papaseit, E.; Garcia-Algar, O. Q.; Farrè, M.; Pacifici, R.; Pichini, S. Determination of Atomoxetine and Its Metabolites in Conventional and Non-conventional Biological Matrices by Liquid Chromatography-Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2012, 60, 26–31.
   PubMed Web of Science ®Google Scholar
• Martínez, M. A.; de la Sánchez, T. C.; Almarza, E. Simultaneous Determination of Viloxazine, Venlafaxine, Imipramine, Desipramine, Sertraline, and Amoxapine in Whole Blood: Comparison of Two Extraction/Cleanup Procedures for Capillary Gas Chromatography with Nitrogen-Phosphorus Detection. J. Anal. Toxicol. 2002, 26, 296–302.
   PubMed Web of Science ®Google Scholar
• Mehta, L.; Singh, J. RP-HPLC Method Development and Validation for the Determination of Bupropion Hydrochloride in a Solid Dosage Form. Res. Rev. J. Pharm. Anal. 2013, 2(3), 1–5.
   Google Scholar
• Miao, H.; Hu, J.; Lu, Y.; Li, Q. Studies on the Adsorptive Behaviour of Mazindol and Its Adsorptive Stripping Voltammetry. Anal. Chim. Acta 1998, 358, 297–303.
   Web of Science ®Google Scholar
• Misiuk, W.; Jasiuk, E. Study of the Inclusion Interaction of HP-γ-cyclodextrin with Bupropion and Its Analytical Application. J. Mol. Struct. 2014, 1060, 272–279.
   Web of Science ®Google Scholar
• Mobrouk, M. M.; El-Fatatry, H. M.; Hammad, S. F.; Mohamed, A. A. Spectrophotometric Methods for Determination of Tapentadol Hydrochloride. J. Appl. Pharm. Sci. 2013, 3, 122–125.
   Google Scholar
• Moore, C. M.; Tebbett, I. R.; Kalita, S.; Artememko, M. Rapid Extraction and Detection of Mazindol in Horse Urine. J. Pharm. Biomed. Anal. 1990, 8, 445–448.
   PubMed Web of Science ®Google Scholar
• Mullen, J. H.; Shugert, R. L.; Ponsler, G. D.; Li, Q.; Sundaram, B.; Coales, H. L.; Yakupkovic, J. E.; Lelacheur, R. M.; Wheeler, W. J., Belas, F. J.; Sauer, J. M. Simultaneous Quantification of Atomoxetine as Well as Its Primary Oxidative and O-glucuronide Metabolites in Human Plasma and Urine Using Liquid Chromatography Tandem Mass Spectrometry (LC/MS/MS). J. Pharm. Biomed. Anal. 2005, 38, 720–733.
   PubMed Web of Science ®Google Scholar
• Nakashima, K.; Kaddoumi, A.; Mori, M.; Nakashima, M. N.; Wada, M.; Aboul Enein, H. Y. High-Performance Liquid Chromatographic Method for the Disposition of Mazindol and Its Metabolite 2-(2-Aminoethyl)-3-(p-chlorophenyl)-3-hydroxyphthalimidine in Mouse Brain and Plasma. Anal. Chim. Acta 2004, 502, 39–47.
   Web of Science ®Google Scholar
• Norman, T. R.; Burrows, G. D.; Davies, B. M.; Wurm, J. M. Determination of Viloxazine in Plasma by GLC. Br. J. Clin. Pharmacol. 1979, 8, 169–171.
   PubMed Web of Science ®Google Scholar
• O’Byrne, P. M.; Williams, R.; Walsh, J. J.; Gilmer, J. F. The Aqueous Stability of Bupropion. J. Pharm. Biomed. Anal. 2010, 53, 376–381.
   PubMed Web of Science ®Google Scholar
• Öhman, D.; Cherma, M. D.; Norlander, B.; Bengtsson, F. Determination of Serum Reboxetine Enantiomers in Patients on Chronic Medication with Racemic Reboxetine. Ther. Drug Monit. 2003, 25, 174–182.
   PubMed Web of Science ®Google Scholar
• Öhman, D.; Norlander, B.; Peterson, C.; Bengtsson, F. Bioanalysis of Racemic Reboxetine and Its Desethylated Metabolite in a Therapeutic Drug Monitoring Setting Using Solid Phase Extraction and HPLC. Ther. Drug Monit. 2001, 23, 27–34.
   PubMed Web of Science ®Google Scholar
• Önal, A.; Sağirli, O.; Cetin, S. M.; Toker, S. A Selective High-Performance Liquid Chromatography Method for the Determination of Reboxetine in Bulk Drug and Tablets. J. AOAC Int. 2006, 89, 1552–1558.
   PubMed Web of Science ®Google Scholar
• Önal, A.; Sağirli, O.; Cetin, S. M.; Toker, S. A Selective LC Method for the Determination of Reboxetine in Human Plasma with Fluorescence Detection. Chromatographia 2007, 66, 103–107.
   Web of Science ®Google Scholar
• Page, M. E.; Brown, K.; Lucki, I. Simultaneous Analyses of the Neurochemical and Behavioral Effects of the Norepinephrine Reuptake Inhibitor Reboxetine in a Rat Model of Antidepressant Action. Psychopharmacology 2003, 165, 194–201.
   PubMed Web of Science ®Google Scholar
• Pan, X.; Xu, Z.; Du, X.; Hu, H.; Fei, A.-L.; Wang, Z.; Xu, R. Determination of Bupropion and Hydroxybupropion by LC-MS/MS in Rat and Its Application to Assessment of CYP2B6 Activity. Lat. Am. J. Pharm. 2012, 31, 858–863.
   Web of Science ®Google Scholar
• Pandya, G. P.; Joshi, H. S. Development and Validation of Stability Indicating HPLC Assay Method for Determination of Tapentadol in Tablet Formulation. Int. J. Sci. Eng. Res. 2013, 4, 1288–1292.
   Google Scholar
• Papoutsis, I.; Khraiwesh, A.; Nikolaou, P.; Pistos, C.; Spiliopoulou, C.; Athanaselis, S. A Fully Validated Method for the Simultaneous Determination of 11 Antidepressant Drugs in Whole Blood by Gas Chromatography–Mass Spectrometry. J. Pharm. Biomed. Anal. 2012, 70, 557–562.
   PubMed Web of Science ®Google Scholar
• Parekh, J. M.; Sutariya, D. K.; Vaghela, R. N.; Sanyal, M.; Yadav, M.; Shrivastav, P. S. Sensitive, Selective and Rapid Determination of Bupropion and Its Major Active Metabolite, Hydroxybupropion, in Human Plasma by LC-MS/MS: Application to a Bioequivalence Study in Healthy Indian Subjects. Biomed. Chromatogr. 2012, 26, 314–326.
   PubMed Web of Science ®Google Scholar
• Patel, C.; Patel, M.; Rani, S.; Nivsarkar, M.; Padh, H. A New High Performance Liquid Chromatographic Method for Quantification of ATX in Human Plasma and Its Application for Pharmacokinetic Study. J. Chromatogr. B 2007, 850, 356–360.
   PubMed Web of Science ®Google Scholar
• Pathade, P.; Pawar, A.; Gaikwad, A.; Panhalkar, A. Development and Validation of Stability Indicating UV Spectrophotometric Method for the Estimation of Atomoxetıne Hydrochloride in Bulk and Tablet Dosage Form. Int. J. Pharm. Bio Sci. 2011, 2, 596–602.
   Google Scholar
• Pérez-Ortiz, M.; Muñoz, C.; Zapata-Urzúa, C.; Alvarez-Lueje, A. Electrochemical Behavior of Atomoxetine and Its Voltammetric Determination in Capsules. Talanta 2010, 82, 398–403.
   PubMed Web of Science ®Google Scholar
• Petsalo, A.; Turpeinen, M.; Tolonen, A. Identification of Bupropion Urinary Metabolites by Liquid Chromatography/Mass Spectrometry. Rapid Commun. Mass Spectrom. 2007, 21, 2547–2554.
   PubMed Web of Science ®Google Scholar
• Prajapati, H. R.; Raveshıya, P. N.; Prajapatı, J. M. RP-HPLC Determination of Atomoxetine Hydrochloride in Bulk and Pharmaceutical Formulations. E-J. Chem. 2011, 8, 1958–1964.
   Google Scholar
• Puyana, M. C.; Garcia, M. A.; Marina, M. L. Enantiomeric Separation of Bupropion Enantiomers by Electrokinetic Chromatography: Quantitative Analysis in Pharmaceutical Formulations. J. Chromatogr. B 2008, 875, 260–265.
   PubMed Web of Science ®Google Scholar
• Qi, M.; Wang, P.; Geng, Y.; Gu, J.; Fu, R. Development and Validation of an HPLC Method for the Determination of Bupropion Hydrochloride in Tablets. J. Chin. Pharm. Sci. 2002, 11, 16–18.
   Google Scholar
• Raggi, M. A.; Bugamelli, F.; Sabbioni, C.; Ferranti, A.; Fanali, S.; Volterra, V. Analysis of Reboxetine, a Novel Antidepressant Drug, in Pharmaceutical Tablets by Capillary Electrophoresis and Derivative Spectrophotometry. J. Pharm. Biomed. Anal. 2002a, 27, 209–215.
   PubMed Web of Science ®Google Scholar
• Raggi, M. A.; Mandrioli, R.; Casamenti, G.; Volterra, V.; Pinzauti, S. Determination of Reboxetine, a Recent Antidepressant Drug, in Human Plasma by Means of Two High-Performance Liquid Chromatography Methods. J. Chromatogr. A 2002b, 949, 23–33.
   PubMed Web of Science ®Google Scholar
• Raggi, M. A.; Mandrioli, R.; Sabbioni, C.; Parenti, C.; Cannazza, G.; Fanali, S. Separation of Reboxetine Enantiomers by Means of Capillary Electrophoresis. Electrophoresis 2002c, 23, 1870–1877.
   PubMed Web of Science ®Google Scholar
• Raghubabu, K.; Swarup, L. S., Ramu, B. K., Narayanarao, M.; Ramdas, C. Assay of Atomoxetine Hydrochloride in Bulk and Its Solid Dosage Forms by Visible Spectrophotometry Usıng Two Aromatic Aldehydes. Rasayan J. Chem. 2011, 4, 784–789.
   Google Scholar
• Rizwana, I.; Prakash, K. V.; Mohan, G. K.; Samreen, J.; Fatima, S. Validated Colorimetric Methods for the Determination of Tapentadol in Bulk and Its Tablet Dosage Form. Int. J. Current Trends Pharm. Res. 2014, 2, 310–314.
   Google Scholar
• Saka, C. High-Performance Liquid Chromatography Methods to Simultaneous Determination of Antiretroviral Drugs in Biological Matrices. Crit. Rev. Anal. Chem. 2009a, 39, 108–125.
   Web of Science ®Google Scholar
• Saka, C. Review of Analytical Methods for Identification and Determination of Triptans. Crit. Rev. Anal. Chem. 2009b, 39, 32–42.
   Web of Science ®Google Scholar
• Saka, C.; Sahin, Ö. Determination of Serotonin–Norepinephrine Reuptake Inhibitor Antidepressants in Pharmaceuticals and Biological Material. Crit. Rev. Anal. Chem. 2013, 43, 2–34.
   Web of Science ®Google Scholar
• Samota, S.; Garg, A.; Pandey, R. The Polarographic Reduction and Electrode Kinetics of Antidepressant Drug Bupropion Hydrochloride. Port. Electrochim. Acta 2010, 28, 87–94.
   Google Scholar
• Sane, R. T.; Francis, M.; Khedkar, S.; Menezrs, A.; Moghe, A.; Patil, P. Gas Chromatographic Determination of Bupropion Hydrochloride from Its Pharmaceutical Formulations. Indian Drugs 2003, 40, 231–233.
   Google Scholar
• Saracino, M. A. C.; Somaini, M. L.; Gerra, G.; Stefano, F. D.; Pieri, M. C.; Raggi, M. A. Simultaneous Determination of Disulfiram and Bupropion in Human Plasma of Alcohol and Nicotine Abusers. Anal. Bioanal. Chem. 2013, 398, 2155–2161.
   Web of Science ®Google Scholar
• Sellers, J. A.; Olsen, B. A.; Owens, P. K.; Gavin, P. F. Determination of the Enantiomer and Positional Isomer Impurities in Atomoxetine Hydrochloride with Liquid Chromatography Using Polysaccharide Chiral Stationary Phases. J. Pharm. Biomed. Anal. 2006, 41, 1088–1094.
   PubMed Web of Science ®Google Scholar
• Şentürk, Z.; Saka, C.; Teğin, İ. Analytical Methods for Determination of Selective Serotonin Reuptake Inhibitor Antidepressants. Rev. Anal. Chem. 2011, 30, 87–122.
   Web of Science ®Google Scholar
• Shraim, N.; Clincke, R.; Sarre, S.; Michotte, Y.; Eeckhaut, A. V. Determination of Reboxetine in Rat Brain Microdialysates and Plasma Samples Using Liquid Chromatography Coupled to Fluorescence Detection. J. Chromatogr. B 2012, 898, 53–61.
   PubMed Web of Science ®Google Scholar
• Soliman, S. M.; El-Agizy, H. M. Y.; El Bayoumi, A. E. A. Validated Stability-Indicating UPLC and Derivative Synchronous Fluorescence Spectroscopy Methods for the Determination of Atomoxetine Hydrochloride in Pharmaceutical Preparation. Pharm. Anal. Acta 2014, 5, 278.
   Google Scholar
• Srikanth, K.; Emmanuel, K. A. Spectrophotometric Determination of Reboxetine through Condensation and Diazo-Coupling Reactions. E-J. Chem. 2011, 8, 281–287.
   Google Scholar
• Suckow, R. F.; Zhang, M. F.; Cooper, T. B. Enantiomeric Determination of the Phenylmorpholinol Metabolite of Bupropion in Human Plasma Using Coupled Achiral–Chiral Liquid Chromatography. Biomed. Chromatogr. 1997, 11, 174–179.
   PubMed Web of Science ®Google Scholar
• Sumalatha, M.; Bharath, K. D.; Geetha, A.; Sisira, S.; Shruthi, A. Validated RP-HPLC Method for the Estimation of Atomoxetine in Pharmaceutical Dosage Forms. Int. J. Res. Pharm. Biomed. Sci. 2012, 3, 1147–1152.
   Google Scholar
• Thakar, D. S.; Varghese, A. Bıoanalytıcal Method Development and Valıdatıon of Bupropıon Hydrochlorıde in Rat Plasma by RP-HPLC. Int. J. Pharm. Biosci. Technol. 2013, 1, 20–26.
   Google Scholar
• Turnpenny, P.; Fraier, D. Sensitive Quantitation of Reboxetine Enantiomers in Rat Plasma and Brain, Using an Optimised Reverse Phase Chiral LC–MS/MS method. J. Pharm. Biomed. Anal. 2009, 49, 133–139.
   PubMed Web of Science ®Google Scholar
• Ulu, S. T. Spectrophotometric and Spectrofluorimetric Determination of Atomoxetine in Pharmaceutical Preparations. Pharmazie 2011, 66, 831–835.
   PubMed Web of Science ®Google Scholar
• Ulu, S. T.; Tuncel, M. Determination of Bupropion Using Liquid Chromatography with Fluorescence Detection in Pharmaceutical Preparations, Human Plasma and Human Urine. J. Chromatogr. Sci. 2012, 50, 433–439.
   PubMed Web of Science ®Google Scholar
• Vujic, Z.; Radulovic, D.; Lucic, B.; Eric, S.; Kuntic, V. UV-Densitometric Determination of Maprotiline, Desipramine and Moclobemide in Pharmaceutical Dosage Forms. Chromatographia 2003, 57, 687–689.
   Web of Science ®Google Scholar
• Waldschmitt, C.; Hiemke, C. Simultaneous Determination of Eight Antidepressant and Two Antipsychotic Drugs with Metabolites in Plasma of Psychiatric Patients Using High Performance Liquid Chromatography (HPLC) with Column Switching and Spectrophotometric Detection. Pharmacopsychiatry 2008, 41, A38.
   Web of Science ®Google Scholar
• Waldschmitt, C.; Vogel, F.; Maurer, C.; Hiemke, C. Measurement of Duloxetine in Blood Using High-Performance Liquid Chromatography with Spectrophotometric Detection and Column Switching. Ther. Drug Monit. 2007, 29, 767–772.
   PubMed Web of Science ®Google Scholar
• Walters, R. R.; Buist, S. C. Improved Enantioselective Method for the Determination of the Enantiomers of Reboxetine in Plasma by Solid-Phase Extraction, Chiral Derivatization, and Column-Switching High-Performance Liquid Chromatography with Fluorescence Detection. J. Chromatogr. A 1998, 828, 167–176.
   PubMed Web of Science ®Google Scholar
• Wang, X.; Vernikovskaya, D. I.; Abdelrahman, D. R.; Hankins, G. D.; Ahmed, M. S.; Nanovskaya, T. N. Simultaneous Quantitative Determination of Bupropion and Its Three Major Metabolites in Human Umbilical Cord Plasma and Placental Tissue Using High-Performance Liquid Chromatography-Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2012, 70, 320–329.
   PubMed Web of Science ®Google Scholar
• Wee, S.; Woolverton, W. L. Evaluation of the Reinforcing Effects of ATX in Monkeys: Comparison to Methylphenidate and Desipramine. Drug Alcohol Depend. 2004, 75, 271–276.
   PubMed Web of Science ®Google Scholar
• Wille, S. M. R.; De Letter, E.; Piette, M.; Overschelde, L. K. V.; Peteghem, C. V.; Lambert, W. Determination of Antidepressants in Human Postmortem Blood, Brain Tissue, and Hair Using Gas Chromatography–Mass Spectrometry. Int.. J. Legal Med. 2009, 123, 451–458.
   Web of Science ®Google Scholar
• Wong, E. H.; Sonders, M. S.; Amara, S. G.; Tinholt, P. M.; Piercey, M. F.; Hoffmann, W. P.; Hyslop, D. K.; Franklin, S.; Porsolt, R. D.; Bonsignori, A.; Carfagna, N.; McArthur, R. A. Reboxetine: A Pharmacologically Potent, Selective, and Specific Norepinephrine Reuptake Inhibitor. Biol. Psychiatry 2000, 47, 818–529.
   PubMed Web of Science ®Google Scholar
• Xia, R.; Che, B.-Q.; Tian, J.; Dong, S.-Y. HPLC Determination of Maprotiline Hydrochloride Tablets and Its Dissolution. Chin. J. Pharm. Anal. 2009, 29(10), 1729–1733.
   Google Scholar
• Xu, Z.; Tang, S. Determination of Mazindol in Tablet by High Performance Liquid Chromatography (HPLC). Chin. J Chromatogr. 1995, 1.
   Google Scholar
• Yeniceli, D.; Dogrukal, A. K. D. The Determination of Bupropion Hydrochloride in Pharmaceutical Dosage Forms by Original UV- and Second Derivative UV Spectrophotometry, Potentiometric and Conductometric Methods. Turk. J. Pharm. Sci. 2010, 7, 99–110.
   Google Scholar
• Yeniceli, D.; Sener, E.; Korkmaz, O.T.; Doğrukol-Ak, D.; Tuncel, N. A Simple and Sensitive LC–ESI-MS (Ion Trap) Method for the Determination of Bupropion and Its Major Metabolite, Hydroxybupropion in Rat Plasma and Brain Microdialysates. Talanta 2011, 84, 19–26.
   PubMed Web of Science ®Google Scholar
• Zhang, D. D.; Yuan, B.; Qiao, M. X.; Li, F. M. HPLC Determination and Pharmacokinetics of Sustained-Release Bupropion Tablets in Dogs. J. Pharm. Biomed. Anal. 2003, 33, 287–93.
   PubMed Web of Science ®Google Scholar
• Zhang, J.; Li, W.; Guo, G.; Zhai, Y.; Guo, W.; Wang, C. Determination of Reboxetine Mesilate in Plasma by High Performance Liquid Chromatography with Ultraviolet Detection. J. Capital Med. Univ. 2008, 29, 431–435.
   Google Scholar
• Zhang, Z.-Q.; Rong, S.-L.; Li, X.-M. Electrochemical Characteristics of Bupropion in the Presence of Surfactant. J. Hunan Univ. (Nat. Sci.) 2005, 6.
   Google Scholar
• Zhu, H. J.; Wang, J. S.; Donovan, J. L.; DeVane, C. L.; Gibson, B. B.; Markowitz, J. S. Sensitive Quantification of Atomoxetine in Human Plasma by HPLC with Fluorescence Detection Using 4-(4,5-Diphenyl-1H-imidazole-2-yl) Benzoyl Chloride Derivatization. J. Chromatogr. B 2007, 846, 351–354.
   PubMed Web of Science ®Google Scholar